enGene Holdings Inc. Common StockENGN
▼ NegativeCapitalrelevance
Q3 GAAP EPS of -$0.47 missed analyst estimates by $0.04.
Impact on stocks 1
Biotech & Genomic Medicine
enGene Holdings Inc. Common StockenGene Holdings reported a third-quarter GAAP loss of $0.47 per share, missing analyst expectations by $0.04. As of July 31, 2026, the company held $266.3 million in cash, cash equivalents, and marketable securities, providing significant operational flexibility.
enGene Holdings Inc. Common StockQ3 GAAP EPS of -$0.47 missed analyst estimates by $0.04.